THEY SAID IT: LAWMAKERS EXPOSE BIG PHARMA’S EGREGIOUS PRICE HIKES AND ANTI-COMPETITIVE TACTICS — DEBUNK BLAME GAME AND EXCUSES
Oct 1, 2020
Lawmakers Blast Big Pharma Executives During Two-Day Hearing on… Read More
© 2024 CSRXP- All Rights Reserved
Updates
CSRXP: ASTRAZENECA LEADS BIG PHARMA IN BRAZEN ASSAULT ON CRITICAL 340B PROGRAM, MUST BE HELD ACCOUNTABLE
Oct 1, 2020
Brand Name Drug Company Shirks Requirement to Provide Affordable Medications… Read More
CSRXP COMMENDS LAWMAKERS FOR REFOCUSING CRITICAL ATTENTION ON BIG PHARMA’S EGREGIOUS PRICE HIKES AND PRACTICES
Sep 30, 2020
House Committee on Oversight and Reform to Question Big Pharma Executives… Read More
DOSE OF REALITY: LAWMAKERS RIGHT TO TRAIN RENEWED FOCUS ON BIG PHARMA’S PRICE-GOUGING AND ANTI-COMPETITIVE TACTICS
Sep 29, 2020
Brand Name Drug Companies Must be Held Accountable for Pandemic Price Hikes… Read More
NEW STUDY: BIG PHARMA’S BIOLOGIC PATENT ABUSE WILL COST AMERICAN PATIENTS AN ADDITIONAL $25 BILLION WITHOUT REFORM
Sep 22, 2020
Report Finds Market-Based Solutions to Boost Biosimilar Competition and Hold… Read More
ICYMI: LA TIMES – VACCINE MAKER GOT $1 BILLION FROM TAXPAYERS. NOW IT’S BOOSTING DRUG PRICES
Sep 15, 2020
Brand Name Drug Maker AstraZeneca Aggressively Raised Prices In The Middle Of… Read More
ICYMI: STUDY SHOWS BIG PHARMA’S ANTI-COMPETITIVE GAMESMANSHIP COMES AT TREMENDOUS COST TO U.S. HEALTHCARE SYSTEM
Sep 14, 2020
Report Finds Just Five Instances Of Product Hopping Sticks Americans With $4.7… Read More
CSRXP: PRESIDENT SHOULD FOCUS ON HOLDING BIG PHARMA ACCOUNTABLE TO LOWER RX PRICES, ABANDON REBATE RULE
Sep 13, 2020
Tweet Misstates Impact of Misguided Rebate Rule That Would Do Nothing to Lower… Read More
ICYMI: REPORT CONFIRMS REBATE RULE WOULD HIKE PREMIUMS, COST TAXPAYERS BILLIONS OF DOLLARS AND BOOST “DRUG COMPANY REVENUES”
Sep 8, 2020
Study Finds Rebates Negotiated By PBMs Reduce Rx Costs and Lower Premiums –… Read More
CSRxP Commends Congressional Probe Of Big Pharma Giant’s Anti-Competitive Tactics and Egregious Pricing Practices
Sep 1, 2020
U.S. House Oversight Committee Subpoena of AbbVie Related to Pricing of… Read More
ICYMI: STAT NEWS – NEW POLL SHOWS WIDE SUPPORT FOR SEVERAL TRUMP DRUG PRICING REFORMS, BUT NOT REBATE CHANGES
Aug 28, 2020
Administration Should Shelve Rebate Rule That Would Increase Medicare… Read More
BIG PHARMA DOUBLES DOWN ON SUMMER PRICE HIKES AS AMERICANS CONTINUE TO BATTLE PANDEMIC
Aug 27, 2020
Tracking Data Finds Drug Companies Increased Prices On at Least 67 Brand Name… Read More